74° Mostly Cloudy

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition

Recent Quotes

View Full List

My Watchlist

Create Watchlist

Indicators

Dow Jones Industrial Average

Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited Ordinary Shares (NY:TEVA)

42.49 +0.58 (+1.38%)

Delayed Quote Updated: 11:35 AM EST, Nov 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited Ordinary Shares

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

35 36 Next >

Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble. ↗

October 04, 2023

The deal leans into the emerging TL1A drug class, potentially rivaling Roivant and Merck.

Via Investor's Business Daily

Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People ↗

October 04, 2023

Sanofi SA (NASDAQ: SNY) and Teva Pharmaceutical Industries Ltd (NYSE: TEVA) have collaborated to co-develop and

Via Benzinga

Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment

October 04, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

October 02, 2023

Via Benzinga

Teva Takes A Run At Its 200-Day Line After Second-Quarter Beat And Raise ↗

August 02, 2023

The company also raised the lower boundary of its guidance for full-year sales.

Via Investor's Business Daily

Teva Announces Changes to Executive Management Team

September 28, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories ↗

September 27, 2023

Benzinga Alibaba's Logistics Arm Cainiao Files For Hong Kong IPO

Via Benzinga

Topics Artificial Intelligence

Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva ↗

September 27, 2023

A federal judge in Massachusetts has overturned a $176.5 million jury verdict against Eli Lilly And Co (NYSE: LLY). T

Via Benzinga

Topics Intellectual Property

Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report ↗

September 26, 2023

Despite significant initiatives by generic drug companies to broaden access to vital medicines, many vulnerable patients remain underserved, according to findings from a new study from the Access to...

Via Benzinga

3 No-Brainer Stocks to Buy With $20 Right Now ↗

September 13, 2023

You don't need a boatload of cash to begin growing your wealth on Wall Street.

Via The Motley Fool

Why Can't You Find Adderall? Inside the Ongoing Shortage of ADHD Medication In US ↗

September 12, 2023

Last year, Teva Pharmaceutical Industries Ltd (NYSE: TEVA), the primary producer of Adderall, faced shortages

Via Benzinga

TEVA - A Pharma Stock To Watch ↗

September 11, 2023

TEVA is one of the few instruments that has handily cleared its July 6-month calendar range high. The 50 daily moving average is about to cross or golden cross the 200-DMA and enter a bullish phase.

Via Talk Markets

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 11, 2023

Via Benzinga

How A Small Indian Firm Firm Was Pulled Into A Legal Battle with Big Pharma Over A Cancer Drug ↗

September 11, 2023

This story was first published on the Benzinga India portal.

Via Benzinga

Bristol Myers' Antitrust Allegations: Lawsuit Over Alleged Patent Deception For Blood Cancer Drug ↗

September 07, 2023

Bristol Myers Squibb Co (NYSE: BMY) faces fresh allegations in a recent lawsuit, accused of employing deceptive patents and illicit strategies to preserve its dominant position in the blood cancer drug...

Via Benzinga

Topics Intellectual Property Lawsuit

Teva to Present at the 21st Annual Morgan Stanley Global Healthcare Conference

September 06, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva to Present Data for AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, AUSTEDO® (deutetrabenazine) Tablets and UZEDY™ (risperidone) Extended-Release Injectable Suspension at Psych Congress 2023

September 06, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

S&P Slashes Ratings Of Five US Banks, SEC Fines Fintech Adviser Titan For Misleading Crypto Claims, Microsoft Modifies Activision Blizzard Purchase: Today's Top Stories ↗

August 22, 2023

Benzinga

Via Benzinga

Topics Regulatory Compliance Stocks

Big Pharma Price-Fixing: Teva and Glenmark's $255M Settlement Shines Light on Industry Issues ↗

August 22, 2023

Drugmaker Teva Pharmaceutical Industries Limited (NYSE: TEVA) has

Via Benzinga

Teva Settles Price Fixing Charges With U.S. DOJ

August 21, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

FDA Greenlights Expanded Use Of Neurocrine Biosciences' Ingrezza: Analysts Weigh In Depression Warning ↗

August 21, 2023

The FDA approved Neurocrine Biosciences Inc's (NASDAQ: NBIX) Ingrezza (valbenazine) capsules for the treatment of adults with chorea associated

Via Benzinga

Supreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits Challenged ↗

August 10, 2023

On Thursday, the Supreme Court temporarily blocked a $6-billion bankruptcy settlement by Purdue Pharma, the maker of the opioid OxyContin, that would shield the Sackler family from civil lawsuits...

Via Benzinga

Topics Bankruptcy Lawsuit

Teva Pharmaceutical, Marathon Oil And 2 Other Stocks Insiders Are Selling ↗

August 10, 2023

The Nasdaq 100 closed lower by over 1% on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Teva Pharmaceutical Industries (TEVA) Q2 2023 Earnings Call Transcript ↗

August 02, 2023

TEVA earnings call for the period ending June 30, 2023.

Via The Motley Fool

Humana, Waters, e.l.f. Beauty, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday ↗

August 02, 2023

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Powell Industries, Inc. (NASDAQ: POWL) shares jumped...

Via Benzinga

Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

August 02, 2023

Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract.

Via Benzinga

Teva Pharma's Stock Soars On Q2 Profit Beat, Highlights Strong Growth From Austedo ↗

August 02, 2023

Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) Q2 sales reached $3.88 billion, up 2% Y/Y (4% on constant currency), slightly beating the

Via Benzinga

Teva Reports Second Quarter 2023 Financial Results

August 02, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development

July 27, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List ↗

July 26, 2023

The World Health Organization (WHO) published the new editions of the Model Lists of Essential Medicines (EML) and Essen

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Teva Pharmaceutical Industries Limited Ordinary Shares (NY:TEVA)

All News about Teva Pharmaceutical Industries Limited Ordinary Shares

Sections

Services